SANTA CLARA, Calif., Nov. 23 /PRNewswire-FirstCall/ -- NewCardio, Inc., a cardiac diagnostic technology provider, announced today that CEO, Dr. Branislav Vajdic, and CFO, Richard Brounstein, will present at the 2nd Annual LD MICRO Conference on Thursday, December 3rd, at 4:30 PM PST at the Luxe Sunset Hotel in Los Angeles.
Dr. Branislav Vajdic, commented, “This year was one of accomplishments. Most notable was the launch of QTinno(TM), our fully automated solution for cardiac safety. And, our many efforts to reinforce our 3-D platform technology - including our wireless focus - should not go unnoticed. We have developed a disruptive technology to target a growing need and look forward to the opportunity to present our vision to this micro-cap investor audience.”
LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors. It is a non-registered investment advisor.
About NewCardio, Inc.
Forward-Looking Statements
To join our email distribution please click this link: http://www.b2i.us/irpass.asp?BzID=1645&to=ea&s=0
NewCardio, Inc.
